HEIDELBERG PHARMA revenue breakdown overview

HEIDELBERG PHARMA revenue for the last year amounted to 11.17 M CHF, the most of which — 6.39 M CHF — came from its highest performing source at the moment, Antibody Drug Conjugates, the year earlier bringing 9.40 M CHF. The greatest contribution to the revenue figure was made by China — last year it brought HEIDELBERG PHARMA 4.36 M CHF, and the year before that — 4.52 M CHF.